CADL ▲ +1.1% - Candel Therapeutics, Inc.
$CADL - Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors
Candel Therapeutics appointed Martine Zimmermann, PharmD, to its board of directors, a move that likely reflected investor confidence in the addition of her pharmaceutical expertise to the company's leadership. The stock rose 1.1% on the announcement.
10-SEP-2026 08:05 AM ET
Share this post
More filings for $CADL
CADL ▲ +1.9% - Candel Therapeutics, Inc.Oct 2, 2026CADL ▼ -2.6% - Candel Therapeutics, Inc.Oct 1, 2026CADL ▼ -0.3% - Candel Therapeutics, Inc.Oct 1, 2026CADL ▲ +0.6% - Candel Therapeutics, Inc.Sep 30, 2026CADL ▲ +0.6% - Candel Therapeutics, Inc.Sep 30, 2026CADL ▼ -2.2% - Candel Therapeutics, Inc.Sep 1, 2026
View full $CADL filing history →💬 Comments
Loading comments…
Leave a comment
